IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION.
This Document Relates To:
In re: Clobetasol Cases All Direct Purchaser, End-Payer, and Indirect Reseller Actions.
In re: Digoxin Cases All Direct Purchaser, End-Payer, and Indirect Reseller Actions.
In re: Divalproex ER Cases All Direct Purchaser, End-Payer, and Indirect Reseller Actions.
In re: Doxycycline Cases All Direct Purchaser, End-Payer, and Indirect Reseller Actions.
In re: Econazole Cases All Direct Purchaser, End-Payer, and Indirect Reseller Actions.
In re: Pravastatin Cases All Direct Purchaser, End-Payer, and Indirect Reseller Actions.
United States District Court, E.D. Pennsylvania.https://leagle.com/images/logo.png
Signed October 16, 2018.
Signed October 16, 2018.
Editors Note
Applicable Law: 15 U.S.C. § 1
Cause: 15 U.S.C. § 1 Antitrust Litigation
Nature of Suit: 410 Other Statutes: Anti - Trust Source: PACER
This multidistrict antitrust litigation alleges that certain pharmaceutical companies engaged in an unlawful scheme or schemes to fix, maintain and stabilize prices, rig bids, and engage in market and customer allocations of certain generic pharmaceutical products. In this Opinion, the...
Let's get started
Welcome to the leading source of independent legal reporting Sign on now to see your case. Or view more than 10 million decisions and orders.
Updated daily.
Uncompromising quality.
Complete, Accurate, Current.
Listed below are the cases that are cited in this Featured Case. Click the citation to see the full
text of the cited case. Citations are also linked in the body of the Featured Case.
Cited Cases
No Cases Found
Listed below are those cases in which this Featured Case is cited. Click on the case name to see the
full text of the citing case.